Cost of renal replacement: How to help as many as possible while keeping expenses reasonable?

Nephrology Dialysis Transplantation

Volumn 31, Issue 8, 2016, Pages 1251-1261

  Vanholder, Raymond ^a   Lameire, Norbert ^a   Annemans, Lieven ^b   Van Biesen, Wim ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Cost; Dialysis; Kidney transplantation; Peritoneal dialysis; Quality of life; Socio economics

Indexed keywords

AGING; BUNDLING; COST CONTROL; DISEASE COURSE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HOME DIALYSIS; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; PATIENT EDUCATION; PATIENT REFERRAL; PERITONEAL DIALYSIS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REIMBURSEMENT; RENAL REPLACEMENT THERAPY; REVIEW; STRATEGIC PLANNING; TIME TO TREATMENT; COST BENEFIT ANALYSIS; ECONOMICS; KIDNEY FAILURE, CHRONIC; QUALITY OF LIFE; STANDARDS;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; KIDNEY FAILURE, CHRONIC; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY;

EID: 84982106727     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv233     Document Type: Review

References (125)

1. St Peter WL, Khan SS, Ebben JP et al. Chronic kidney disease: the distribution of health care dollars. Kidney Int 2004; 66: 313-321
2. Smith DH, Gullion CM, Nichols G et al. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004; 15: 1300-1306
3. Andersen MJ, Friedman AN. The coming fiscal crisis: nephrology in the line of fire. Clin J Am Soc Nephrol 2013; 8: 1252-1257
4. Klarenbach S, Manns B. Economic evaluation of dialysis therapies. Semin Nephrol 2009; 29: 524-532
5. Antwi S. State of renal replacement therapy services in Ghana. Blood Purif 2015; 39: 137-140
6. Hoerger TJ, Simpson SA, Yarnoff BO et al. The future burden of CKD in the United States: a simulation model for the CDC CKD initiative. Am J Kidney Dis 2015; 65: 403-411
7. Icks A, Haastert B, Gandjour A et al. Costs of dialysis-a regional population-based analysis. Nephrol Dial Transplant 2010; 25: 1647-1652
8. Mayosi BM, Flisher AJ, Lalloo UG et al. The burden of non-communicable diseases in South Africa. Lancet 2009; 374: 934-947
9. Rubin RJ. Understanding Washington: a nephrologist's perspective from inside the Beltway. Am J Kidney Dis 2013; 62: 1042-1045
10. Vanholder R, Van BiesenW, Lameire N. Renal replacement therapy: how can we contain the costs? Lancet 2014; 383: 1783-1785
11. VanholderR,Davenport A, HannedoucheTet al. Reimbursement of dialysis: a comparison of seven countries. J AmSoc Nephrol 2012; 23: 1291-1298
12. Wong G, Howard K, Chapman JR et al. Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLOS One 2012; 7: e29591
13. Kutner NG, Zhang R, Barnhart H et al. Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis. Nephrol Dial Transplant 2005; 20: 2159-2167
14. Jassal SV,Watson D. Dialysis in late life: benefit or burden? Clin J Am Soc Nephrol 2009; 4: 2008-2012
15. Cleemput I, De Laet C. Analysis of the costs of dialysis and the effects of an incentive mechanism for low-cost dialysis modalities. Health Policy 2013; 110: 172-179
16. Khawar O, Kalantar-Zadeh K, Lo WK et al. Is the declining use of longterm peritoneal dialysis justified by outcome data? Clin J Am Soc Nephrol 2007; 2: 1317-1328
17. Chow KM, Li PK. Dialysis: Choice of dialysis-what to do with economic incentives. Nature Rev Nephrol 2012; 8: 495-496
18. Dor A, PaulyMV, EichleayMAet al. End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF). Int J Health Care Finance Econ 2007; 7: 73-111
19. Desai AA, Bolus R, Nissenson A et al. Identifying best practices in dialysis care: results of cognitive interviews and a national survey of dialysis providers. Clin J Am Soc Nephrol 2008; 3: 1066-1076
20. Hasegawa T, Bragg-Gresham JL, Pisoni RL et al. Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin. Kidney Int 2011; 79: 340-346
21. Kute VB, Vanikar AV, Shah PR et al. Increasing access to kidney transplantation in countries with limited resources: the Indian experience with kidney paired donation. Nephrology 2014; 19: 599-604
22. Schold JD, Segev DL. Increasing the pool of deceased donor organs for kidney transplantation. Nat Rev Nephrol 2012; 8: 325-331
23. Friedman AL, Friedman EA. A step toward solving the long-term care dilemma for living kidney donors. Transplantation 2012; 94: 988-989
24. Abadie A, Gay S. The impact of presumed consent legislation on cadaveric organ donation: a cross-country study. J Health Econ 2006; 25: 599-620
25. Boyarsky BJ, Hall EC, Deshpande NA et al. Potential limitations of presumed consent legislation. Transplantation 2012; 93: 136-140
26. Zivcic-Cosic S, Busic M, Zupan Z et al. Development of the Croatian model of organ donation and transplantation. Croat Med J 2013; 54: 65-70
27. Heilman RL, Smith ML, Kurian SM et al. Transplanting kidneys from deceased donors with severe acute kidney injury. Am J Transplant 2015, doi:10. 1111/ajt. 13260
28. Schold JD, Kaplan B, Baliga RS et al. The broad spectrum of quality in deceased donor kidneys. Am J Transplant 2005; 5: 757-765
29. Sever MS, Kazancioglu R, Yildiz A et al. Outcome of living unrelated (commercial) renal transplantation. Kidney Int 2001; 60: 1477-1483
30. Zargooshi J. Quality of life of Iranian kidney donors. J Urol/I 2001; 166: 1790-1799
31. Ghods AJ, Savaj S. Iranian model of paid and regulated living-unrelated kidney donation. Clin J Am Soc Nephrol 2006; 1: 1136-1145
32. Tong A, Chapman JR,Wong G et al. Perspectives of transplant physicians and surgeons on reimbursement, compensation, and incentives for living kidney donors. Am J Kidney Dis 2014; 64: 622-632
33. Garg PP, Furth SL, Fivush BA et al. Impact of gender on access to the renal transplant waiting list for pediatric and adult patients. J Am Soc Nephrol 2000; 11: 958-964
34. Grams ME, Kucirka LM, Hanrahan CF et al. Candidacy for kidney transplantation of older adults. J Am Geriatr Soc 2012; 60: 1-7
35. Cass A, Cunningham J, Snelling P et al. Renal transplantation for Indigenous Australians: identifying the barriers to equitable access. Ethn Health 2003; 8: 111-119
36. Balhara KS, Kucirka LM, Jaar BG et al. Disparities in provision of transplant education by profit status of the dialysis center. Am J Transplant 2012; 12: 3104-3110
37. Van BiesenW, Vanholder RC, VeysNet al. An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol 2000; 11: 116-125
38. Moist LM, Port FK, Orzol SM et al. Predictors of loss of residual renal function among new dialysis patients. J AmSoc Nephrol 2000; 11: 556-564
39. Goldfarb-Rumyantzev AS, Hurdle JF, Scandling JD et al. The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival. Am J Kidney Dis 2005; 46: 537-549
40. Rosner MH. Cost of renal replacement therapy. Nephrol Dial Transplant 2013; 28: 2399-2401
41. Churchill DN, Torrance GW, TaylorDWet al. Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med 1987; 10: 14-20
42. Baboolal K, McEwan P, Sondhi S et al. The cost of renal dialysis in a UK setting-a multicentre study. Nephrol Dial Transplant 2008; 23: 1982-1989
43. Berger A, Edelsberg J, Inglese GW et al. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease. Am J Manag Care 2009; 15: 509-518
44. Just PM, de Charro FT, Tschosik EA et al. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol Dial Transplant 2008; 23: 2365-2373
45. Morton RL, Devitt J, Howard K et al. Patient views about treatment of stage 5 CKD: a qualitative analysis of semistructured interviews. Am J Kidney Dis 2010; 55: 431-440
46. Jain AK, Blake P, Cordy P et al. Global trends in rates of peritoneal dialysis. J Am Soc Nephrol 2012; 23: 533-544
47. Horl WH, de Alvaro F, Williams PF. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: access to ESRD treatments. Nephrol Dial Transplant 1999; 14 (Suppl 6): 10-15
48. Dimkovic N, Oreopoulos D. Management of elderly patients with endstage kidney disease. Semin Nephrol 2009; 29: 643-649
49. Marron B, Martinez Ocana JC, Salgueira M et al. Analysis of patient flow into dialysis: role of education in choice of dialysis modality. Perit Dial Int 2005; 25 (Suppl. 3): S56-S59
50. Marshall MR, van der Schrieck N, Lilley D et al. Independent community house hemodialysis as a novel dialysis setting: an observational cohort study. Am J Kidney Dis 2013; 61: 598-607
51. Vanholder R, Eloot S, Neirynck N et al. Home haemodialysis and uraemic toxin removal: does a happy marriage exist? Nat Rev Nephrol 2012; 8: 579-588
52. Pauly RP, Gill JS, Rose CL et al. Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients. Nephrol Dial Transplant 2009; 24: 2915-2919
53. Rocco MV, Lockridge RS, Jr, Beck GJ et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 2011; 80: 1080-1091
54. Daugirdas JT, Greene T, Rocco MV et al. Effect of frequent hemodialysis on residual kidney function. Kidney Int 2013; 83: 949-958
55. Tennankore KK, d'Gama C, Faratro R et al. Adverse technical events in home hemodialysis. Am J Kidney Dis 2015; 65: 116-121
56. Walker RC, Hanson CS, Palmer SC et al. Patient and caregiver perspectives on home hemodialysis: a systematic review. Am J Kidney Dis 2015; 65: 451-463
57. Osterlund K, Mendelssohn D, Clase C et al. Identification of facilitators and barriers to home dialysis selection by Canadian adults with ESRD. Semin Dial 2014; 27: 160-172
58. Yu YJ, Wu IW, Huang CY et al. Multidisciplinary predialysis education reduced the inpatient and total medical costs of the first 6 months of dialysis in incident hemodialysis patients. PLOS One 2014; 9: e112820
59. Van BiesenW, van der Veer SN, MurpheyMet al. Patients' perceptions of information and education for renal replacement therapy: an independent survey by the European Kidney Patients' Federation on information and support on renal replacement therapy. PLOS One 2014; 9: e103914
60. Palmer SC, Hanson CS, Craig JC et al. Dietary and fluid restrictions in CKD: a thematic synthesis of patient views from qualitative studies. Am J Kidney Dis 2015. doi:10. 1053/j. ajkd. 2014. 09. 012
61. Keating PT,Walsh M, Ribic CM et al. The impact of patient preference on dialysis modality and hemodialysis vascular access. BMC Nephrol 2014; 15: 38
62. Locatelli F, Barany P, Covic A et al. Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European renal best practice position statement. Nephrol Dialysis Transplant 2013; 28: 1346-1359
63. Moss AH, Davison SN. How the ESRD quality incentive program could potentially improve quality of life for patients on dialysis. Clin J Am Soc Nephrol 2015, doi:10. 2215/CJN. 07410714
64. Kinchen KS, Sadler J, Fink N et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 2002; 137: 479-486
65. Goransson LG, Bergrem H. Consequences of late referral of patients with end-stage renal disease. J Intern Med 2001; 250: 154-159
66. Manns BJ, Taub K, Vanderstraeten C et al. The impact of education on chronic kidney disease patients' plans to initiate dialysis with self-care dialysis: a randomized trial. Kidney Int 2005; 68: 1777-1783
67. Thamer M, Zhang Y, Kaufman J et al. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis. JAMA 2007; 297: 1667-1674
68. Viglino G, Neri L, Alloatti S et al. Analysis of the factors conditioning the diffusion of peritoneal dialysis in Italy. Nephrol Dial Transplant 2007; 22: 3601-3605
69. Agar JW. Personal viewpoint: hemodialysis-water, power, and waste disposal: rethinking our environmental responsibilities. Hemodial Int 2012; 16: 6-10
70. Agar JW. Green dialysis: the environmental challenges ahead. Semin Dial 2015; 28: 186-192
71. Heaf JG, Axelsen M, Pedersen RS. Multipass haemodialysis: a novel dialysis modality. Nephrol Dial Transplant 2013; 28: 1255-1264
72. Upadhyay A, Sosa MA, Jaber BL. Single-use versus reusable dialyzers: the known unknowns. Clin J Am Soc Nephrol 2007; 2: 1079-1086
73. Bond TC, Nissenson AR, Krishnan M et al. Dialyzer reuse with peracetic acid does not impact patient mortality. Clin J Am Soc Nephrol 2011; 6: 1368-1374
74. Lacson E, Jr,WangW, Mooney A et al. Abandoning peracetic acid-based dialyzer reuse is associated with improved survival. Clin J Am Soc Nephrol 2011; 6: 297-302
75. Labib ME, Murawski J, Tabani Y et al. Water permeability of high-flux dialyzer membranes after Renalin reprocessing. Kidney Int 2007; 71: 1177-1180
76. Susantitaphong P, Altamimi S, AshkarMet al
77. Rosansky SJ, Eggers P, Jackson K et al. Early start of hemodialysis may be harmful. Arch Intern Med 2011; 171: 396-403
78. Lee J, An JN, Hwang JH et al. Effect of dialysis initiation timing on clinical outcomes: a propensity-matched analysis of a prospective cohort study in Korea. PLOS One 2014; 9: e105532
79. Cooper BA, Branley P, Bulfone L et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010; 363: 609-619
80. Tattersall J, Dekker F, Heimburger O et al. When to start dialysis: updated guidance following publication of the initiating dialysis early and late (IDEAL) study. Nephrol Dial Transplant 2011; 26: 2082-2086
81. Lameire N, Van Biesen W. The initiation of renal-replacement therapy-just-in-time delivery. New Engl J Med 2010; 363: 678-680
82. Wolfe RA, Held PJ, Hulbert-Shearon TE et al. A critical examination of trends in outcomes over the last decade. American J Kidney Dis 1998; 32 (Suppl. 4): S9-S15
83. Harris A, Cooper BA, Li JJ et al. Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis 2011; 57: 707-715
84. Palmer AJ, Annemans L, Roze S et al. Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patients with type 2 diabetes, hypertension, and renal disease. Diabetes Care 2004; 27: 1897-1903
85. Hayry M. Public health and human values. J Med Ethics 2006; 32: 519-521
86. Komenda P, Ferguson TW, Macdonald K et al. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis 2014; 63: 789-797
87. Schanstra JP, Zurbig P, Alkhalaf A et al. Diagnosis and prediction of CKD progression by assessment of urinary peptides. J Am Soc Nephrol 2015. doi:10. 1681/ASN. 2014050423
88. Rayner HC, Baharani J, Dasgupta I et al. Does community-wide chronic kidney disease management improve patient outcomes? Nephrol Dial Transplant 2014; 29: 644-649
89. Lopez-Vargas PA, Tong A, Phoon RK et al. Knowledge deficit of patients with stage 1-4 CKD: a focus group study. Nephrology 2014; 19: 234-243
90. Rossing K, Mischak H, DaknaMet al. Urinary proteomics in diabetes and CKD. J Am Soc Nephrol 2008; 19: 1283-1290
91. Levey AS, Cattran D, Friedman A et al. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 2009; 54: 205-226
92. Brantsma AH, Bakker SJ, Hillege HL et al. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant 2008; 23: 3851-3858
93. Rombach SM, Hollak CE, Linthorst GE et al. Cost-effectiveness of enzyme replacement therapy for Fabry disease. Orphanet J Rare Dis 2013; 8: 29
94. Joutsenniemi K, Harkanen T, Pankakoski M et al. Confidence in the future, health-related behaviour and psychological distress: results from a web-based cross-sectional study of 101 257 Finns. BMJ Open 2013; 3: e002397
95. Vart P, Gansevoort RT, Crews DC et al. Mediators of the association between low socioeconomic status and chronic kidney disease in the United States. Am J Epidemiol 2015; 181: 385-396
96. Bello AK, Levin A, Manns BJ et al. Effective CKD care in European countries: challenges and opportunities for health policy. Am J Kidney Dis 2015; 65: 15-25
97. Chudek J,Wieczorowska-Tobis K, Zejda J et al. The prevalence of chronic kidney disease and its relation to socioeconomic conditions in an elderly Polish population: results from the national population-based study Pol-Senior. Nephrol Dial Transplant 2014; 29: 1073-1082
98. Boult C, Altmann M, Gilbertson D et al. Decreasing disability in the 21st century: the future effects of controlling six fatal and nonfatal conditions. Am J Public Health 1996; 86: 1388-1393
99. Anderson S, Halter JB, Hazzard WR et al. Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol 2009; 20: 1199-1209
100. Roderick PJ, Atkins RJ, Smeeth L et al. CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis 2009; 53: 950-960
101. Drey N, Roderick P, Mullee M et al. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 2003; 42: 677-684
102. Kurella Tamura M, Cohen LM. Should there be an expanded role for palliative care in end-stage renal disease? Curr Opin Nephrol Hypertens 2010; 19: 556-560
103. Davison SN. End-of-life care preferences and needs: perceptions of patients with chronic kidney disease. Clin J AmSoc Nephrol 2010; 5: 195-204
104. Kurella Tamura M, Covinsky KE, Chertow GM et al
105. Canaud B, Tong L, Tentori F et al. Clinical practices and outcomes in elderly hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2011; 6: 1651-1662
106. Grun RP, Constantinovici N, Normand C et al. North Thames Dialysis Study G. Costs of dialysis for elderly people in the UK. Nephrol Dial Transplant 2003; 18: 2122-2127
107. Lamping DL, Constantinovici N, Roderick P et al. Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study. Lancet 2000; 356: 1543-1550
108. Muthalagappan S, Johansson L, Kong WM et al. Dialysis or conservative care for frail older patients: ethics of shared decision-making. Nephrol Dial Transplant 2013; 28: 2717-2722
109. Vandecasteele SJ, Kurella TamuraM. A patient-centered vision of care for ESRD: dialysis as a bridging treatment or as a final destination? J Am Soc Nephrol 2014; 25: 1647-1651
110. Brown MA, Collett GK, Josland EA et al. CKD in elderly patients managed without dialysis: survival, symptoms, and quality of life. Clin J Am Soc Nephrol 2015; 10: 260-268
111. Jassal SV. Four plus forty-four: hours to modify, theirs to enjoy. Clin J Am Soc Nephrol 2015; 10: 169-171
112. Schaeffner ES, Rose C, Gill JS. Access to kidney transplantation among the elderly in the United States: a glass half full, not half empty. Clin J Am Soc Nephrol 2010; 5: 2109-2114
113. Curtis JJ. Ageism and kidney transplantation. Am J Transplant 2006; 6: 1264-1266
114. Meier-Kriesche HU, Schold JD, Gaston RS et al. Kidneys from deceased donors: maximizing the value of a scarce resource. Am J Transplant 2005; 5: 1725-1730
115. Krzesinski JM, Sumaili KE, Cohen E. How to tackle the avalanche of chronic kidney disease in sub-Saharan Africa: the situation in the Democratic Republic of Congo as an example. Nephrol Dial Transplant 2007; 22: 332-335
116. Sumaili EK, Cohen EP, Zinga CV et al. High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol 2009; 10: 18
117. Cooper R, Rotimi C, Ataman S et al. The prevalence of hypertension in seven populations of West African origin. Am J Public Health 1997; 87: 160-168
118. Cappuccio FP, Micah FB, Emmett L et al. Prevalence, detection, management, and control of hypertension in Ashanti,West Africa. Hypertension 2004; 43: 1017-1022
119. Finkelstein FO, Abdallah TB, Pecoits-Filho R. Peritoneal dialysis in the developing world: lessons from the Sudan. Perit Dial Int 2007; 27: 529-530
120. Swanepoel CR, Wearne N, Okpechi IG. Nephrology in Africa-not yet uhuru. Nat Rev Nephrol 2013; 9: 610-622
121. Moosa MR, Kidd M. The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int 2006; 70: 1107-1114
122. Tantivess S,Werayingyong P, Chuengsaman P et al. Universal coverage of renal dialysis in Thailand: promise, progress, and prospects. BMJ 2013; 346: f462
123. Arije A, Kadiri S, Akinkugbe OO. The viability of hemodialysis as a treatment option for renal failure in a developing economy. Afr J Med Med Sci 2000; 29: 311-314
124. D'Hoore E, Neirynck N, Schepers E et al. Chronic kidney disease progression is mainly associated with non-recovery of acute kidney injury. J Nephrol 2015, doi:10. 1007/s40620-015-0181-5
125. Tong A, Chando S, Crowe S et al. Research priority detting in kidney disease: a systematic review. Am J Kidney Dis 2015, doi:10. 1053/j. ajkd. 2014. 11. 011